Your browser doesn't support javascript.
loading
Using the first nationwide survey on non-communicable disease risk factors and different definitions to evaluate the prevalence of metabolic syndrome in Burkina Faso.
Cissé, Kadari; Samadoulougou, Délwendé René Séverin; Bognini, Joel Dofinissery; Kangoye, Tiga David; Kirakoya-Samadoulougou, Fati.
Affiliation
  • Cissé K; Centre de Recherche en Epidémiologie, Biostatistiques et Recherche Clinique, Ecole de Santé Publique, Université libre de Bruxelles, Brussels, Belgium.
  • Samadoulougou DRS; Departement Biomédical et Santé Publique, Institut de Recherche en Sciences de la Santé, Ouagadougou, Burkina Faso.
  • Bognini JD; Service de Médecine, Centre Hospitalier Régional de Banfora, Banfora, Burkina Faso.
  • Kangoye TD; Centre National de la Recherche Scientifique et Technologique, Unité de Recherche Clinique de Nanoro, Institut de Recherche en Sciences de la Santé, Ouagadougou, Burkina Faso.
  • Kirakoya-Samadoulougou F; Institut national de santé publique (INSP), CNRFP, Ouagadougou, Burkina Faso.
PLoS One ; 16(8): e0255575, 2021.
Article de En | MEDLINE | ID: mdl-34351987
BACKGROUND: The burden of cardiovascular diseases is rising in the developing world including Sub-Saharan Africa. The rapid rise of cardiovascular disease burden is in part due to undetected and uncontrolled cardiovascular risk factors. The clustering of metabolic syndrome (MetS) components is associated with a high risk of cardiovascular diseases. This complex biochemical disorder is still poorly studied in western Africa. In this study, we aimed to determine the prevalence of metabolic syndrome and its determinants among the adult population in Burkina Faso. METHODS: We performed a secondary analysis of the data from the first national survey on non-communicable diseases risk factors using the World Health Organization (WHO) Stepwise approach. We included 4019 study participants aged 25 to 64 years. The metabolic syndrome prevalence was estimated using six different definitions. RESULTS: The mean age was 38.6±11.1 years. Women represented 52.4% and three quarters (75%) lived in rural areas. The overall prevalence of metabolic syndrome according to the different definitions was 1.6% (95%CI:1.1-2.2) for the American College of Endocrinology, 1.8% (95%CI: 1.3-2.4) for the WHO, 4.3% (95%CI:3.5-5.2) for the National Cholesterol Education Program Adult Treatment Panel III, 6.2% (95%CI: 5.1-7.6) for the AAH/NHBI, 9.6%(95%CI: 8.1-11.3) for the International Diabetes Federation and 10.9% (95%: 9.2-12.7) for the Joint Interim Statement. The metabolic syndrome components with the highest prevalence were low High density lipoprotein (63.3%), abdominal obesity (22.3%) and hypertension (20.6%). People living in urban areas and those with older age have higher prevalence of metabolic syndrome regardless of the definition used. CONCLUSION: Our findings suggest various levels of prevalence of MetS according to the definition used. Identifying the most appropriate criteria for MetS among the adult population is important to early detect and treat this syndrome and its components at the primary health care level to control the rising burden of cardiovascular diseases in the context of ongoing epidemiological transition in the country.
Sujet(s)

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Enquêtes de santé / Syndrome métabolique X / Maladies non transmissibles Type d'étude: Etiology_studies / Evaluation_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limites: Adult / Female / Humans / Male / Middle aged Pays/Région comme sujet: Africa Langue: En Journal: PLoS One Sujet du journal: CIENCIA / MEDICINA Année: 2021 Type de document: Article Pays d'affiliation: Belgique Pays de publication: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Enquêtes de santé / Syndrome métabolique X / Maladies non transmissibles Type d'étude: Etiology_studies / Evaluation_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limites: Adult / Female / Humans / Male / Middle aged Pays/Région comme sujet: Africa Langue: En Journal: PLoS One Sujet du journal: CIENCIA / MEDICINA Année: 2021 Type de document: Article Pays d'affiliation: Belgique Pays de publication: États-Unis d'Amérique